Cytomos is an Edinburgh, UK based biotech company pioneering a new class of label-free, single-cell analysis technology with the potential to deliver a novel and disruptive capability in explorative drug discovery and profiling. The intrinsic nature of Cytomos technology enables unbiased sample assessment with powerful machine learning algorithms capable of revealing potentially unprecedented information regarding patient drug response and mechanisms of action.
